|
CN109694855A
|
|
The method that human epidermal stem cell induction is corneal epithelial cell efficiency is improved using transgenic technology
|
|
CN111875674A
|
|
Improved method for differentiation of epidermal stem cells into pancreatic cells
|
|
CN108893473A
|
|
RAB23 gene knockout is carried out using CRISPR-Cas system in epidermal stem cells
|
|
CN108715850A
|
|
GING2 gene knockouts are carried out using CRISPR-Cas systems in epidermal stem cells
|
|
CN108707604A
|
|
CNE10 gene knockouts are carried out using CRISPR-Cas systems in epidermal stem cells
|
|
CN108610399A
|
|
The method that specificity enhancing CRISPR-CAS systems carry out gene editing efficiency in epidermal stem cells
|
|
CN108392624A
|
|
Activity promotes the application of peptide and mescenchymal stem cell in treating rheumatoid arthritis
|
|
CN108451981A
|
|
Use skin mesenchymal stem cells treatment system sclerosis
|
|
CN108404112A
|
|
Raising candidate stem cell is gone back to the nest and the method and its reagent of implantation rate
|
|
CN108410806A
|
|
A kind of storage liquid of people's lung mescenchymal stem cell
|
|
CN108378019A
|
|
A kind of frozen stock solution of people's stem spermatogonium
|
|
CN107686827A
|
|
Human adipose-derived stem cell special media
|
|
CN107619829A
|
|
The method for carrying out GINS2 gene knockouts to mescenchymal stem cell using CRISPR cas systems
|
|
CN107586779A
|
|
The method for carrying out CASP3 gene knockouts to mescenchymal stem cell using CRISPR cas systems
|
|
CN107474129A
|
|
The method of specificity enhancing CRISPR cas system gene editing efficiency
|
